Faecal transplant helps defeat multidrug-resistant infections: study
Some patients with blood diseases benefitted from improved quality of life, researchers found
Chronically ill patients infected with multidrug-resistant organisms during care for serious conditions may benefit from faecal microbiota transplantation (FMT), a pilot study suggests.
In the study, 20 patients with intestinal colonisation by multidrug-resistant organisms (MDROs) were followed.
The sample included patients with chronic haematological disease in need of stem-cell transplant and kidney-transplant patients with recurrent urinary and bloodstream infections.
MDROs included carbapenemase-producing Enterobacteriaceae and vancomycin-resistant Enterococci or extended-spectrum beta-lactamase Enterobacteriaceae.
